Register for your FREE account now and join the thousands of healthcare professionals who have depended on us for over 26 years for accurate, concise, and timely drug information.

Keep me logged in Forgot your password?

Please wait...

Please wait...

Ob/Gyn Resource Center

Welcome to the MPR Ob/Gyn Resource Center, where you will find everything you need to make informed clinical decisions.

News

ATS: Effects of Prenatal Pollution Exposure Persist

Maternal pollutant exposure has lasting effect on lung function development in children with asthma
 

Prenate Mini Vitamins Now Available

Avion Pharmaceuticals announced the launch of Prenate Mini, a once-daily easy-to-swallow prenatal vitamin capsule.
 

Diet Intervention Most Useful in Reducing Pregnancy Weight Gain

For pregnant women, dietary and lifestyle interventions are associated with a reduction in maternal gestational weight gain, with the largest reduction and improved pregnancy outcomes seen with dietary interventions.
 

Recurrent HTN Seen for Half of Women With HTN in Pregnancy

About half of women who experience a hypertensive disorder of pregnancy and late-preterm delivery develop a hypertensive disorder in a subsequent pregnancy, although few have delivery before 37 weeks in the subsequent pregnancy.
 

Sunscreen Ingredient May Be Linked to Risk of Endometriosis

Benzophenone (BP)-type derivatives may be linked to an increased risk of endometriosis.
 

New Drugs

NEXPLANON

11/30/2011

Pharmacological Class: Progestin.
Active Ingredient(s): Etonogestrel 68mg, barium sulfate 15mg; radiopaque; implantable rod; latex-free.
Indication: Subdermal contraception.
 

LO LOESTRIN FE

5/18/2011

Pharmacological Class: Progestin + estrogen.
Active Ingredient(s): Norethindrone acetate 1mg, ethinyl estradiol 10mcg (24 tabs), ethinyl estradiol 10mcg (2 tabs); inert+ (2 tabs); +contains ferrous fumarate 75mg.
Indication: Oral contraception.
 

MAKENA

4/14/2011

Pharmacological Class: Progestin.
Active Ingredient(s): Hydroxyprogesterone caproate 250mg/mL; for deep IM inj; contains castor oil, benzyl benzoate, benzyl alcohol.
Indication: To reduce risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth. Not intended for use in patients with multiple gestations or other risk factors for preterm birth.
 

ClinicalJobAdvisor

Loading...

More Jobs

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions